The management and outcome of women with post-hydatidiform mole |[lsquo]|low-risk|[rsquo]| gestational trophoblastic neoplasia, but hCG levels in excess of 100|[thinsp]|000|[thinsp]|IU|[thinsp]|l|[minus]|1

S McGrath; D Short; R Harvey; P Schmid; P M Savage; M J Seckl

【24h】

The management and outcome of women with post-hydatidiform mole |[lsquo]|low-risk|[rsquo]| gestational trophoblastic neoplasia, but hCG levels in excess of 100|[thinsp]|000|[thinsp]|IU|[thinsp]|l|[minus]|1

机译：葡萄胎后葡萄胎| [lsquo] |低风险| [rsquo] |的治疗和结果妊娠滋养细胞肿瘤，但hCG水平超过100 | [thinsp] | 000 | [thinsp] | IU | [thinsp] | l | [负] | 1

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:Gestational trophoblastic neoplasia (GTN) after a hydatidiform mole is either treated with single- or multi-agent chemotherapy determined by a multifactorial scoring system. Women with human chorionic gonadotrophin (hCG) levels >100?000?IU?l?1 can remain within the low-risk/single-agent category and usually choose one drug therapy. Here we compare the success and duration of single- vs multi-agent chemotherapy in this patient group.

机译：背景：葡萄胎后葡萄胎的滋养细胞赘生物（GTN）可通过单因素或多因素化疗通过多因素评分系统确定。人绒毛膜促性腺激素（hCG）水平> 100？000？IU？l？1 1的女性可以保持在低风险/单药类别中，并且通常选择一种药物疗法。在这里，我们比较了该患者组中单药与多药化疗的成功率和持续时间。

著录项

来源
《British Journal of Cancer》 |2010年第5期|共5页
作者
S McGrath; D Short; R Harvey; P Schmid; P M Savage; M J Seckl;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia? [J] . Braga Antonio, Biscaro Andressa, do Amaral Giordani Jessye Melgarejo, European Journal of Obstetrics, Gynecology and Reproductive Biology: An International Journal . 2018,第期

机译：在子宫疏散的子宫疏散后，人绒毛膜促性腺激素水平超过20,000 iu / l是否构成了妊娠期滋养细胞瘤形成的化学疗法的指示？
2. Efficacy of Oral Vitamin A in Reducing β-hCG Levels in Low-Risk Gestational Trophoblastic Neoplasia Patients [J] . Yudi Mulyana Hidayat, Eppy Darmadi A, Sylvia Rachmayati, Asian Pacific Journal of Cancer Prevention . 2020,第11期

机译：口服维生素A在降低低风险妊娠期滋养细胞肿瘤患者中β-HCG水平的疗效
3. Serum hCG level and rising world health organization score at second-line chemotherapy (pulse dactinomycin): poor prognostic factors for methotrexate-failed low-risk gestational trophoblastic neoplasia. [J] . Kang WD, Kim CH, Cho MK, International journal of gynecological cancer: official journal of the International Gynecological Cancer Society . 2010,第8期

机译：二线化疗（脉冲放线菌素）时的血清hCG水平和世界卫生组织评分上升：甲氨蝶呤失败的低危妊娠滋养细胞瘤形成的预后不良。
4. The management and outcome of women with post-hydatidiform mole ‘low-risk gestational trophoblastic neoplasia but hCG levels in excess of 100 000 IU l−1 [O] . S McGrath, D Short, R Harvey, 2010

机译：葡萄胎后葡萄胎低危妊娠滋养细胞性肿瘤但hCG水平超过100 000 IU l-1的妇女的管理和结果
5. The management and outcome of women with post-hydatidiform mole ‘low-risk' gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l−1 [O] . McGrath, S, Short, D, Harvey, R, 2010

机译：葡萄胎后葡萄胎“低危”滋养细胞赘生性肿瘤但hCG水平超过100 000 IU l-1的妇女的管理和结果

The management and outcome of women with post-hydatidiform mole |[lsquo]|low-risk|[rsquo]| gestational trophoblastic neoplasia, but hCG levels in excess of 100|[thinsp]|000|[thinsp]|IU|[thinsp]|l|[minus]|1

摘要

著录项

相似文献

相关主题

期刊订阅